Drug Shortage Report for TEVA-COTRIDIN EXPECTORANT

Last updated on 2023-04-28 History
Report ID 153712
Drug Identification Number 02053403
Brand name TEVA-COTRIDIN EXPECTORANT
Common or Proper name TEVA-COTRIDIN EXPECTORANT SYRUP 500ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) CODEINE PHOSPHATE GUAIFENESIN PSEUDOEPHEDRINE HYDROCHLORIDE TRIPROLIDINE HYDROCHLORIDE
Strength(s) 10MG 100MG 30MG 2MG
Dosage form(s) SYRUP
Route of administration ORAL ORAL
Packaging size 500,2L
ATC code R05FA
ATC description COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-01-27
Estimated end date 2023-03-20
Actual end date 2023-04-27
Shortage status Resolved
Updated date 2023-04-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v29 2023-04-28 English Compare
v28 2023-04-27 French Compare
v27 2023-04-27 English Compare
v26 2023-02-16 French Compare
v25 2023-02-16 English Compare
v24 2023-02-02 French Compare
v23 2023-02-02 English Compare
v22 2023-01-12 French Compare
v21 2023-01-12 English Compare
v20 2022-12-01 English Compare
v19 2022-12-01 French Compare
v18 2022-12-01 English Compare
v17 2022-09-07 French Compare
v16 2022-09-07 English Compare
v15 2022-06-30 French Compare
v14 2022-06-30 English Compare
v13 2022-06-16 French Compare
v12 2022-06-16 English Compare
v11 2022-06-09 French Compare
v10 2022-06-09 English Compare

Showing 1 to 20 of 29